Lantus

Lantus

insulin glargine

Manufacturer:

Sanofi-Aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Insulin glargine
Indications/Uses
DM in adults, adolescents & childn ≥2 yr, where treatment w/ insulin is required.
Dosage/Direction for Use
Individualised dosage. By SC inj once daily at the same time everyday.
Contraindications
Special Precautions
Impaired liver function & moderate to severe renal impairment. Hypo- & hyperglycaemia. Concomitant illness. May affect ability to drive or operate machinery. Childn <2 yr.
Adverse Reactions
Hypoglycaemia, temporary visual impairment, lipoatrophy or lipohypertrophy at the inj site & allergic reactions including severe swelling of skin or mucous membranes, shortness of breath, fall in BP, shock.
Drug Interactions
Increased blood sugar-lowering effect when used w/ oral antidiabetics, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates & sulfonamides. Decreased blood sugar-lowering effect when used w/ corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, OCs, phenothiazine derivatives, somatropin, sympathomimetic agents, thyroid hormones, atypical antipsychotic drugs & PIs. β-blockers, clonidine & lithium salts or alcohol may weaken or potentiate blood sugar-lowering effect. Pentamidine may cause hypoglycaemia, sometimes followed by hyperglycaemia.
ATC Classification
A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
Presentation/Packing
Form
Lantus SoloSTAR pre-filled pen 100 U/mL
Packing/Price
3 mL x 5 × 1's
Form
Lantus inj 100 U/mL
Packing/Price
10 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in